Literature DB >> 17158410

Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials.

Katherine M Appleton1, Robert C Hayward, David Gunnell, Tim J Peters, Peter J Rogers, David Kessler, Andrew R Ness.   

Abstract

BACKGROUND: Greater dietary intakes of n-3 long-chain polyunsaturated fatty acids (n-3 PUFAs) may be beneficial for depressed mood.
OBJECTIVE: This study aimed to systematically review all published randomized controlled trials investigating the effects of n-3 PUFAs on depressed mood.
DESIGN: Eight medical and health databases were searched over all years of records until June 2006 for trials that exposed participants to n-3 PUFAs or fish, measured depressed mood, were conducted on human participants, and included a comparison group.
RESULTS: Eighteen randomized controlled trials were identified; 12 were included in a meta-analysis. The pooled standardized difference in mean outcome (fixed-effects model) was 0.13 SDs (95% CI: 0.01, 0.25) in those receiving n-3 PUFAs compared with placebo, with strong evidence of heterogeneity (I2 = 79%, P < 0.001). The presence of funnel plot asymmetry suggested that publication bias was the likely source of heterogeneity. Sensitivity analyses that excluded one large trial increased the effect size estimates but did not reduce heterogeneity. Meta-regression provided some evidence that the effect was stronger in trials involving populations with major depression-the difference in the effect size estimates was 0.73 (95% CI: 0.05, 1.41; P = 0.04), but there was still considerable heterogeneity when trials that involved populations with major depression were pooled separately (I2 = 72%, P < 0.001).
CONCLUSIONS: Trial evidence that examines the effects of n-3 PUFAs on depressed mood is limited and is difficult to summarize and evaluate because of considerable heterogeneity. The evidence available provides little support for the use of n-3 PUFAs to improve depressed mood. Larger trials with adequate power to detect clinically important benefits are required.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158410     DOI: 10.1093/ajcn/84.6.1308

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  45 in total

Review 1.  Omega-3 fatty acids for depression in adults.

Authors:  Katherine M Appleton; Hannah M Sallis; Rachel Perry; Andrew R Ness; Rachel Churchill
Journal:  Cochrane Database Syst Rev       Date:  2015-11-05

2.  Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus.

Authors:  Toshimasa Sakamoto; Mehmet Cansev; Richard J Wurtman
Journal:  Brain Res       Date:  2007-09-21       Impact factor: 3.252

3.  Are dietary recommendations for the use of fish oils sustainable?

Authors:  David J A Jenkins; John L Sievenpiper; Daniel Pauly; Ussif Rashid Sumaila; Cyril W C Kendall; Farley M Mowat
Journal:  CMAJ       Date:  2009-03-17       Impact factor: 8.262

4.  Impact of diet on adult hippocampal neurogenesis.

Authors:  Doris Stangl; Sandrine Thuret
Journal:  Genes Nutr       Date:  2009-08-15       Impact factor: 5.523

Review 5.  Role of docosahexaenoic acid in maternal and child mental health.

Authors:  Usha Ramakrishnan; Beth Imhoff-Kunsch; Ann M DiGirolamo
Journal:  Am J Clin Nutr       Date:  2009-01-28       Impact factor: 7.045

6.  Fish consumption and omega-3 polyunsaturated fatty acids in relation to depressive episodes: a cross-sectional analysis.

Authors:  Anna Liisa Suominen-Taipale; Timo Partonen; Anu W Turunen; Satu Männistö; Antti Jula; Pia K Verkasalo
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

7.  Update and critique of natural remedies as antidepressant treatments.

Authors:  David Mischoulon
Journal:  Obstet Gynecol Clin North Am       Date:  2009-12       Impact factor: 2.844

8.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

9.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

10.  Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder.

Authors:  Robert K McNamara
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.